Yourgene Health PLC The Healthcare+ Expo Taiwan
December 05 2019 - 6:10AM
RNS Non-Regulatory
TIDMYGEN
Yourgene Health PLC
05 December 2019
Yourgene Health plc
("Yourgene" or the "Group" or the "Company")
The Healthcare+ Expo Taiwan
Manchester, UK - 5 December 2019: Yourgene (AIM: YGEN), a
leading international molecular diagnostics group, announces it
will be exhibiting and presenting at The Healthcare+ Expo Taiwan,
from the 5-8 December 2019 at stand R241, Hall 2 in the Taipei
Nangang Exhibition Centre, Taiwan City, Taiwan.
The Expo brings together over 600 exhibitors, working in the
advanced medicine and leading technology space and is a key Asia
Pacific forum for interdisciplinary collaborations.
Two Key Opinion Leaders, Dr Min-Ji Charng and Dr Shu-Han You,
will be making clinical educational presentations on behalf of
Yourgene, along with a collaborating partner for bioinformatics for
genomic research, Allen Chang. Details of the presentation are
below:
Speaker: Allen Chang, CEO ATgenomix
Topic: Next Generation Bio-IT: A Unified High-quality Sequencing and
High-performance Computing Solution for Genomics Research
Date: 6 December 2019
Time: 11:00 am CST (GMT +8)
Speaker: Dr Min-Ji Charng, Director of Coronary Care Unit Taipei Veterans
General Hospital
Topic: Why cholesterol is so high in my family? Genetic testing for
high cholesterol in Taiwan
Date: 6 December 2019
Time: 2:00 pm CST (GMT +8)
Speaker: Dr Shu-Han You, Lecturer & attending physician Chang Gung Memorial
Hospital, Linkou
Topic: Clinical Application of Whole Exome Sequencing in Prenatal
and Postnatal Diagnosis
Date: 6 December 2019
Time: 3:00 pm CST (GMT +8)
Lyn Rees, CEO of Yourgene Health plc, said: "We are particularly
pleased to be showcasing all our products and services from the
Taipei lab at the annual Taiwan Expo as well as having our clinical
customers showcase their expertise with Yourgene's services."
Yourgene Health plc Tel: +44 (0)161 669 8122
Lyn Rees, Chief Executive Officer investors@yourgene-health.com
Barry Hextall, Chief Financial Officer
Joanne Cross, Director of Marketing
Stifel Nicolaus Europe Limited (Sole Tel: +44 (0)20 7710 7600
Corporate Broker)
Nicholas Moore / Matthew Blawat / Ben
Maddison
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com
Relations) Mob: 07980 541 893 Mob: 07584 391 303
Paul McManus / Lianne Cawthorne
About Yourgene Health
Yourgene Health is an international molecular diagnostics group
which develops and commercialises genetic products and services.
The group works in partnership with global leaders in DNA
technology to advance diagnostic science.
Yourgene develops and commercialises simple and accurate
molecular diagnostic solutions, primarily for reproductive health.
The Group's products include non-invasive prenatal tests (NIPT) for
Down's Syndrome and other genetic disorders, Cystic Fibrosis
screening tests, invasive rapid aneuploidy tests, male infertility
tests and genetic disease tests. Yourgene's commercial footprint is
already established in the UK, Europe, the Middle East, Africa and
Asia.
Our product development, research service and commercial
capabilities extend across the lifecycle of genetic test
development including regulatory submissions. Through our technical
expertise and partnerships, Yourgene Health is also extending its
genetic testing offering into oncology.
Yourgene Health is headquartered in Manchester, UK with offices
in Taipei and Singapore, and is listed on the London Stock
Exchange's AIM market under the ticker "YGEN". For more
information, visit www.yourgene-health.com and follow us on twitter
@Yourgene_Health.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRABDBDDXGGBGCU
(END) Dow Jones Newswires
December 05, 2019 07:10 ET (12:10 GMT)
Premaitha (LSE:NIPT)
Historical Stock Chart
From May 2024 to Jun 2024
Premaitha (LSE:NIPT)
Historical Stock Chart
From Jun 2023 to Jun 2024